Related Experiment Video
Updated: Aug 9, 2026
06:19
Skin Punch Biopsy Explant Culture for Derivation of Primary Human Fibroblasts
Published on: July 7, 2013
Apoptosis and schizophrenia: a pilot study based on dermal fibroblast cell lines
Vibeke Sørensen Catts1, Stanley Victor Catts, John Joseph McGrath
1School of Biotechnology and Biomolecular Science, University of New South Wales, Sydney NSW 2052 Australia.
Schizophrenia Research
|April 22, 2006
Summary
Schizophrenia patients exhibit altered apoptosis in fibroblasts, with increased basal apoptosis but an attenuated response to inducers. This suggests unique apoptotic pathway dysregulation in schizophrenia.
Area of Science:
- Cell biology
- Neuroscience
- Psychiatry
Background:
- Schizophrenia is a complex psychiatric disorder.
- Apoptosis, or programmed cell death, plays a role in cellular homeostasis.
- Investigating apoptosis in schizophrenia may reveal underlying biological mechanisms.
Purpose of the Study:
- To determine if fibroblasts from schizophrenia patients show increased susceptibility to apoptosis.
- To compare apoptosis markers in schizophrenia, non-schizophrenic psychosis, and healthy control groups.
- To explore the regulation of apoptotic pathways in schizophrenia.
Main Methods:
- Fibroblast cell lines were cultured from patients with schizophrenia, non-schizophrenic psychosis, and healthy controls.
- Apoptosis susceptibility was assessed by measuring sub-G0 cell fraction, activated caspase-3, and apoptosis regulators (P53, Bax, Bcl-2).
- Cells were analyzed under basal conditions and after exposure to cycloheximide, an apoptosis inducer.
Main Results:
- Fibroblasts from schizophrenia patients had a higher proportion of sub-G0 cells under basal conditions compared to the non-schizophrenic psychosis group.
- However, the schizophrenia group showed a weaker caspase-3 response when apoptosis was induced by cycloheximide.
- Correlations between apoptosis regulators and caspase-3 differed in the schizophrenia group, indicating dysregulated apoptotic pathways.
Conclusions:
- Schizophrenia is associated with anomalous apoptotic mechanisms distinct from non-schizophrenic psychosis.
- These apoptotic anomalies in fibroblasts suggest they may be present in other somatic cells in schizophrenia.
- Altered apoptosis could be a potential biomarker or therapeutic target in schizophrenia research.
Related Concept Videos
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...